Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) recently announced that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold Pharmaceuticals’ small molecule hypoxia-targeted drug. TH-302 is currently being investigated in a global Phase 3 clinical trial in patients with soft tissue sarcoma, a randomized Phase 2 trial in patients with advanced pancreatic cancer from which top-line results are expected in February, as well as additional clinical studies in other solid tumors and hematological malignancies. Under the terms of the agreement, Merck will receive co-development rights, exclusive global commercialization rights and will provide Threshold Pharmaceuticals an option to co-commercialize the therapeutic in the United States.

In exchange, Threshold Pharmaceuticals will receive an upfront payment of $25 million and could receive up to $35 million in additional development milestones during 2012. Threshold Pharmaceuticals is also eligible to receive a $20 million milestone payment based on positive results from its randomized Phase 2 trial in pancreatic cancer. Total potential milestone payments are $525 million, comprised of $280 million in regulatory and development milestones and $245 million in sales-based milestones.

For more information about Threshold Pharmaceuticals, please visit: www.thresholdpharm.com

********************************

PerkinElmer, Inc. (NYSE:PKI), a global leader focused on improving the health and safety of people and the environment, announced that Peter Barrett, a partner at Atlas Venture, an early stage technologies and life sciences venture capital fund, has been elected to the Company’s Board of Directors, in anticipation of a current Board member reaching retirement age.

PerkinElmer, Inc. provides technology, services, and solutions to the diagnostics, research, environmental and safety, and industrial and laboratory services markets worldwide.

********************************

Kenexa Corporation (NYSE:KNXA), a global provider of business solutions for human resources, announced that Andrew Goldschmidt has been named chief customer officer. By promoting Goldschmidt to CCO, Kenexa solidifies its commitment to providing outstanding customer service to its clients.

Kenexa Corporation and its subsidiaries provide software, proprietary content, and services that enable organizations to recruit and retain employees.

********************************

Majestic Gold Corp. (MJGCF.PK)

Majestic Gold Corp. engages in the exploration and development of mineral properties in China. The company focuses on its gold project located in the prolific gold region of Song Jiagou in eastern Shandong Province. Majestic Gold Corp. is headquartered in Vancouver, Canada.

Gold is metallic, with a yellow colour when in a mass, but when finely divided it may be black, ruby, or purple. It is the most malleable and ductile metal; 1 ounce (28 g) of gold can be beaten out to 300 square feet. It is a soft metal and is usually alloyed to give it more strength. It is a good conductor of heat and electricity, and is unaffected by air and most reagents. Gold is usually alloyed in jewellery to give it more strength, and the term carat describes the amount of gold present (24 carats is pure gold). It is estimated that all the gold in the world, so far refined, could be placed in a single cube 60 ft. on a side.

Majestic Gold Corp. (MJGCF.PK) has arranged a $10,000,000 loan to advance its Song Jiagou project in China. Nine million dollars ($9,000,000) from the proceeds from the loan will be used by the Company to in connection with its Song Jiagou project and the balance of one million dollars ($1,000,000) for general working capital purposes.

The loan will have a one year term and loan principal will be convertible at the option of the lender in whole or in part into common shares (”Shares”) of the Company until twelve months from the date of the loan advance at the price of $0.205 per Share. The loan will bear interest at the rate of 7.5% per annum, payable on maturity, and accrued and unpaid interest will be convertible at the option of the lender in whole or in part into shares of the Company until twelve months from the date of the loan advance at Market Price at the time of conversion.

The lender is at arm’s length from the Company and will not become an insider as a result of any conversion of principal and interest. All shares issued on any conversion of loan principal or interest will be subject to a four month hold period from the date of advance of loan proceeds. The loan is subject to acceptance by the TSX Venture Exchange.

As additional consideration for the loan, the Company has agreed to forward at least $9 million to Majestic Yantai Gold Ltd., a British Virgin Islands company owned 94% by the Company to be used to further advance its Song Jiagou project. The Borrower has also agreed to a 90 day period for reciprocal due diligence reviews and discussions for the possible further involvement of the Lender in the Song Jiagou project.

In the event that no further agreement is reached between the Lender and the Company during the 90 day period, then the loan and a minimum of seven (7) months interest will automatically convert to shares in the Company at a price of $0.205 per share and the interest at Market Price respectively. In addition the Company is pleased to announce that it has arranged a non-brokered private placement of up to 15,000,000 shares to be issued at the price of $0.20 per share for gross proceeds of $3,000,000.

For more information about company: www.majesticgold.net

********************************

MicroFinancial Incorporated (Nasdaq:MFI), a financial intermediary specializing in vendor-based leasing and finance programs for microticket transactions, announced financial results for the fourth quarter and the year ended December 31, 2011. Increased net income by 69.8% to $9.0 million or $0.62 per diluted share as compared to $5.3 million in 2010; Increased revenues on finance leases by 7.7% to $37.0 million and increased total revenues 7.4% to $54.7 million as compared to 2010; Net income for the fourth quarter of 2011 increased by 54.5% to $2.4 million or $0.16 per diluted share based upon 14,547,820 shares, compared to net income of $1.5 million, or $0.11 per diluted share based upon 14,494,654 shares for the same period last year. Revenue in the fourth quarter of 2011 increased by 7.6% to $14.1 million compared to $13.1 million in the fourth quarter of 2010 due primarily to increases in leasing revenues associated with new lease originations and rental revenue. Revenue from leases was $9.5 million, an increase of $0.5 million from the same period last year and rental income was $2.3 million, an increase of $0.3 million from the quarter ended December 31, 2010. Other revenue components contributed $2.3 million for the current quarter, an increase of $0.2 million from the same period last year.

Microfinancial Incorporated, through its subsidiaries, operates as a specialized commercial finance company that provides microticket equipment leasing and rental, and other financing services in the United States.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company.Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Tags: Kenexa, Majestic Gold, MicroFinancial, MJGCF, Nasdaq:MFI, Nasdaq:THLD, NYSE:KNXA, NYSE:PKI, PerkinElmer, Stocks In Focus, Threshold Pharmaceuticals

This entry was posted on Saturday, February 4th, 2012 at 9:16 am and is filed under Stock Alerts. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.